Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
BACKGROUND: The World Health Organization currently recommends combined streptomycin and rifampicin antibiotic treatment as first-line therapy for Mycobacterium ulcerans infections. Alternatives are needed when these are not tolerated or accepted by patients, contraindicated, or neither accessible n...
Saved in:
Main Authors: | Daniel P O'Brien (Author), Anthony McDonald (Author), Peter Callan (Author), Mike Robson (Author), N Deborah Friedman (Author), Andrew Hughes (Author), Ian Holten (Author), Aaron Walton (Author), Eugene Athan (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
by: Daniel P O'Brien, et al.
Published: (2018) -
Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes.
by: Daniel P O'Brien, et al.
Published: (2015) -
Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area.
by: Daniel P O'Brien, et al.
Published: (2014) -
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
by: Raquel Cowan, et al.
Published: (2015) -
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
by: N Deborah Friedman, et al.
Published: (2013)